Martire G, Villani G R, Della Morte R, Belisario M A, Pecce R, Staiano N
Dipartimento di Biochimica e Biotechnologie Mediche, Università degli Studi di Napoli, Italy.
Carcinogenesis. 1991 Feb;12(2):361-4. doi: 10.1093/carcin/12.2.361.
1-Amino-8-nitropyrene (1,8-ANP), a product of 1,8-dinitropyrene metabolism by either bacterial or mammalian enzymes, is weakly mutagenic to the 'classical nitroreductase'-deficient Salmonella tester strain TA98NR. The addition to the test system of rat liver cytosol without cofactors did not produce any effect on the 1,8-ANP mutagenic response toward TA98NR strain. Conversely, when both rat hepatic cytosol and NADPH (1 mM) were added to the mutagenicity assay, a 10-fold increase in 1,8-ANP mutagenic activity was observed. This suggests the involvement of rat hepatic cytosolic NADPH-dependent nitroreductase(s) in 1,8-ANP mutagenic activation. The addition to the mutagenesis assay of pentachlorophenol, an inhibitor of O-acetyltransferase and sulfotransferase, produced a dose-dependent decrease of 1,8-ANP mutagenic activation, whereas 2,6-dichloro-4-nitrophenol, a more specific inhibitor of sulfotransferase than O-acetyltransferase, did not affect the activation of 1,8-ANP to a mutagen at concentrations that selectively inhibit only bacterial sulfotransferase. This indicates that bacterial O-acetyltransferase but not sulfotransferase plays a role in the mutagenic activation of 1,8-ANP. Addition of acetyl co-enzyme A (AcCoA) and adenosine 3'-phosphate 5'-phosphosulfate (PAPS), cofactors for O-acetyl-transferase and sulfotransferase respectively, to the test system caused a dose-dependent inhibition of 1,8-ANP mutagenic activation by rat liver cytosol and NADPH, probably due to the formation of highly reactive O-acetoxy and N-sulfate ester derivatives of 1,8-ANP, which react with nucleophilic sites before reaching bacterial DNA. This hypothesis was confirmed by DNA covalent binding in in vitro experiments showing that both the cofactors AcCoA and PAPS enhanced the NADPH/rat liver cytosol-mediated covalent binding of 1,8-ANP to DNA from calf thymus 10- and 3-fold respectively. It seems likely that rat hepatic cytosolic nitroreductases activate 1,8-ANP to an N-hydroxyarylamine derivative which can be further metabolized to mutagenic species by either bacterial or mammalian O-acetyltransferase.
1-氨基-8-硝基芘(1,8-ANP)是1,8-二硝基芘经细菌或哺乳动物酶代谢后的产物,对缺乏“经典硝基还原酶”的沙门氏菌测试菌株TA98NR具有弱致突变性。在测试体系中添加无辅因子的大鼠肝细胞溶胶,对1,8-ANP对TA98NR菌株的致突变反应没有任何影响。相反,当将大鼠肝细胞溶胶和NADPH(1 mM)都添加到致突变性测定中时,观察到1,8-ANP的致突变活性增加了10倍。这表明大鼠肝细胞质中依赖NADPH的硝基还原酶参与了1,8-ANP的致突变激活过程。在诱变测定中添加五氯苯酚(一种O-乙酰转移酶和磺基转移酶的抑制剂),会导致1,8-ANP致突变激活的剂量依赖性降低,而2,6-二氯-4-硝基苯酚(一种比O-乙酰转移酶更特异性的磺基转移酶抑制剂),在仅选择性抑制细菌磺基转移酶的浓度下,并不影响1,8-ANP向诱变剂的激活。这表明细菌的O-乙酰转移酶而非磺基转移酶在1,8-ANP的致突变激活中起作用。分别向测试体系中添加O-乙酰转移酶和磺基转移酶的辅因子乙酰辅酶A(AcCoA)和3'-磷酸腺苷5'-磷酸硫酸酯(PAPS),会导致大鼠肝细胞溶胶和NADPH对1,8-ANP致突变激活的剂量依赖性抑制,这可能是由于形成了1,8-ANP的高反应性O-乙酰氧基和N-硫酸酯衍生物,它们在到达细菌DNA之前就与亲核位点发生反应。这一假设在体外实验中的DNA共价结合实验中得到了证实,实验表明辅因子AcCoA和PAPS分别使NADPH/大鼠肝细胞溶胶介导的1,8-ANP与小牛胸腺DNA的共价结合增强了10倍和3倍。似乎大鼠肝细胞质中的硝基还原酶将1,8-ANP激活为N-羟基芳胺衍生物,该衍生物可通过细菌或哺乳动物的O-乙酰转移酶进一步代谢为致突变物质。